COVID-19 Antigen Template: FDA Adds Info On Asymptomatics Studies, Multiplex Tests
Executive Summary
The US agency on 26 October updated its emergency use authorization template to include a somewhat lengthy section on recommendations for clinical studies of asymptomatic people, as well as guidance for makers of multiplex tests that screen for the coronavirus and influenza.
You may also be interested in...
87636 And 87637: New CPT Codes From AMA For COVID-19/Flu Combo Antigen Tests
The American Medical Association has added two new Current Procedural Terminology (CPT) codes for reporting antigen tests that detect COVID-19 and influenza. And a third new code, 87811, should be used to report “infectious agent antigen detection by immunoassay with direct visual observation.”
FDA Boosts Development Of OTC COVID-19 Tests With New Template
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?